GB0227906D0 - Compounds and their use - Google Patents

Compounds and their use

Info

Publication number
GB0227906D0
GB0227906D0 GBGB0227906.5A GB0227906A GB0227906D0 GB 0227906 D0 GB0227906 D0 GB 0227906D0 GB 0227906 A GB0227906 A GB 0227906A GB 0227906 D0 GB0227906 D0 GB 0227906D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0227906.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paradigm Therapeutics Ltd
Original Assignee
Amedis Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amedis Pharmaceuticals Ltd filed Critical Amedis Pharmaceuticals Ltd
Priority to GBGB0227906.5A priority Critical patent/GB0227906D0/en
Publication of GB0227906D0 publication Critical patent/GB0227906D0/en
Priority to AU2003302625A priority patent/AU2003302625A1/en
Priority to PCT/GB2003/005056 priority patent/WO2004050666A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
GBGB0227906.5A 2002-11-29 2002-11-29 Compounds and their use Ceased GB0227906D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0227906.5A GB0227906D0 (en) 2002-11-29 2002-11-29 Compounds and their use
AU2003302625A AU2003302625A1 (en) 2002-11-29 2003-11-20 Silicon compounds useful in cancer therapy
PCT/GB2003/005056 WO2004050666A1 (en) 2002-11-29 2003-11-20 Silicon compounds useful in cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0227906.5A GB0227906D0 (en) 2002-11-29 2002-11-29 Compounds and their use

Publications (1)

Publication Number Publication Date
GB0227906D0 true GB0227906D0 (en) 2003-01-08

Family

ID=9948795

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0227906.5A Ceased GB0227906D0 (en) 2002-11-29 2002-11-29 Compounds and their use

Country Status (3)

Country Link
AU (1) AU2003302625A1 (en)
GB (1) GB0227906D0 (en)
WO (1) WO2004050666A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007019221A2 (en) * 2005-08-03 2007-02-15 Rnd Pharmaceuticals, Inc. Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs
ES2746105T3 (en) 2014-10-08 2020-03-04 Epigenetics Pharma Llc Silylated 5-aza-pyrimidine prodrugs useful for treating cancer
US10227374B2 (en) 2016-04-21 2019-03-12 Ohara Pharmaceutical Co., Ltd. Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety
WO2017183215A1 (en) 2016-04-21 2017-10-26 大原薬品工業株式会社 Sugar moiety silyl ether derivative of 5-azacytidine
JP6162349B1 (en) 2016-04-21 2017-07-12 大原薬品工業株式会社 Sacyl moiety silyl ether derivatives of 5-azacytidines
WO2018230479A1 (en) * 2017-06-13 2018-12-20 大原薬品工業株式会社 5'-position silyl ether derivative for nucleoside anti-cancer agent or anti-virus agent

Also Published As

Publication number Publication date
AU2003302625A1 (en) 2004-06-23
WO2004050666A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
GB0220214D0 (en) Compounds and their use
GB0227906D0 (en) Compounds and their use
GB0300805D0 (en) Compounds and their use
GB0300804D0 (en) Compounds and their use
GB0301143D0 (en) Compounds and their use
GB0230134D0 (en) Compounds and their use
GB0317864D0 (en) Compounds and their use
GB0230281D0 (en) Compounds and their use
GB0220215D0 (en) Compounds and their use
GB0317133D0 (en) Compounds and their use
GB0220217D0 (en) Compounds and their use
GB0227447D0 (en) Compounds and their use
GB0227131D0 (en) Compounds and their use
GB0226752D0 (en) Compounds and their use
GB0226751D0 (en) Compounds and their use
GB0224554D0 (en) Compounds and their use
GB0227905D0 (en) Compounds and their use
GB0227448D0 (en) Compounds and their use
GB0230066D0 (en) Compounds and their use
GB0230067D0 (en) Compounds and their use
GB0228056D0 (en) Compounds and their use
GB0227904D0 (en) Compounds and their use
GB0230135D0 (en) Compounds and their uses
GB0314292D0 (en) Compounds and their use
GB0304819D0 (en) Compounds and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)